Richard /ca/ Murray's Net Worth

$5.21 Million

Estimate Recalculated Sep 8, 2024 07:26PM EST

Who is Richard /ca/ Murray?

Richard /ca/ Murray has an estimated net worth of $5.21 Million. This is based on reported shares across multiple companies, which include Jounce Therapeutics, Inc., and PDL BIOPHARMA, INC..

SEC CIK

Richard /ca/ Murray's CIK is 0001242935

Past Insider Trading and Trends

2004 was Richard /ca/ Murray's most active year for acquiring shares with 8 total transactions. Richard /ca/ Murray's most active month to acquire stocks was the month of January. 2005 was Richard /ca/ Murray's most active year for disposing of shares, totalling 21 transactions. Richard /ca/ Murray's most active month to dispose stocks was the month of December. 2005 saw Richard /ca/ Murray paying a total of $395,851.75 for 63,387 shares, this is the most they've acquired in one year. In 2005 Richard /ca/ Murray cashed out on 119,874 shares for a total of $1,739,761.98, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Jounce Therapeutics, Inc. No price found

CEO and President

Richard /ca/ Murray owns 1 units of Common Stock. In the year 2017 Richard /ca/ Murray acquired a total of 532,188 shares in Jounce Therapeutics, Inc. at a cost of $107,840.64, Richard also disposed a total of 532,187 shares of Jounce Therapeutics, Inc. equalling to $2,923,814.86.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-188.78K
—
—
1
May 3
Form 4
-17.20%
-39.23K
$1.85
-$72,571.80
188.78K
Apr 4
Form 4
-16.50%
-45.07K
$1.11
-$50,074.58
228.01K
Jan 9 - Jan 10
Form 4
+47.15%
87.5K
—
—
273.08K
Feb 1
Form 4
-16.73%
-37.29K
$6.88
-$256,695.60
185.58K
Jan 7 - Jan 10
Form 4
+58.77%
82.5K
—
—
222.87K
Feb 1 - Feb 3
Form 4
—
0
$6.27
-$388,138.44
140.37K
Scheduled
Jan 21
Form 4
—
0
$5.09
-$796,731.92
140.37K
Scheduled
Jan 15 - Jan 20
Form 4
-13.55%
-22.00K
$6.89
-$151,549.08
140.37K
Jan 7 - Jan 8
Form 4
+85.86%
75.01K
—
—
162.37K
Feb 3
Form 4
-7.57%
-7.15K
$7.78
-$55,627.00
87.36K
Jan 7
Form 4
—
0
$4.43
-$315,600.00
94.51K
Scheduled
Dec 23
Form 4
+195.34%
62.51K
—
—
94.51K
Feb 1
Form 4
∞
32K
$0.48
$15,360.00
32K
Sep 6
Form 4
—
0
$12.79
-$402,143.08
0
Scheduled
Mar 8
Form 4
—
0
$10.96
-$342,202.72
0
Scheduled
Mar 5
Form 4
—
0
—
—
0
Feb 1
Form 3
—
0
—
—
0
No matching records found

PDL BIOPHARMA, INC. No price found

EVP & CSO

Richard /ca/ Murray owns 70,159 units of Common Stock. From 2004 to 2008 Richard /ca/ Murray acquired a total of 203,706 shares in PDL BIOPHARMA, INC. at a cost of $861,101.75, Richard also disposed a total of 140,067 shares of PDL BIOPHARMA, INC. equalling to $3,255,350.67.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.12%
-1.52K
$10.98
-$16,678.62
70.16K
Jul 21
Form 4
-1.98%
-1.45K
$10.56
-$15,280.32
71.68K
Jul 14
Form 4
+37.65%
20K
$7.85
$157,000.00
73.13K
Apr 28
Form 4
—
0
—
—
0
Aug 15
Form 4
-2.86%
-1.52K
$25.93
-$39,387.67
51.61K
Jul 20
Form 4
-2.65%
-1.45K
$26.22
-$37,940.34
53.13K
Jul 13
Form 4
—
0
—
—
0
Feb 15
Form 4
+45.25%
17K
—
—
54.57K
Jul 20
Form 4
-3.71%
-1.45K
$17.40
-$25,195.20
37.57K
Jul 13
Form 4
—
0
$20.39
-$348,421.54
39.02K
Scheduled
Mar 3 - Mar 6
Form 4
—
0
$19.59
-$183,840.20
39.02K
Scheduled
Sep 6
Form 4
-20.40%
-10.00K
$17.01
-$658,863.03
39.02K
Scheduled
Aug 3
Form 4
+49.36%
16.2K
—
—
49.02K
Jul 13
Form 4
-24.24%
-10.50K
$13.93
-$337,575.00
32.82K
Scheduled
Jun 20
Form 4
-5.46%
-2.50K
$13.95
-$80,678.00
43.32K
Scheduled
Feb 1
Form 4
-5.17%
-2.50K
$14.18
-$82,954.00
45.82K
Scheduled
Jan 3
Form 4/A
-9.38%
-5.00K
$13.93
-$160,815.00
48.32K
Scheduled
Dec 14
Form 4
-4.48%
-5.00K
$13.93
-$160,815.00
106.64K
Scheduled
Dec 14
Form 4
-4.48%
-2.50K
$14.02
-$81,305.00
53.32K
Scheduled
Oct 4
Form 4
-15.19%
-10.00K
$13.93
-$321,500.00
55.82K
Scheduled
Sep 13
Form 4/A
—
0
—
—
0
Jul 23
Form 4
—
0
—
—
0
Jul 23
Form 4/A
∞
65.82K
—
—
65.82K
Apr 4
No matching records found